Xeris Pharmaceuticals | XERS - 股票

金融业

USD

USD 392.01M

现金及等价物

USD 111.75M

USD 13.66M

USD 251.68M

USD 118.59M

USD 257.65M

USD 16.77M

USD 25.09M

377

EPS每股收益

USD 0.01

股本和储备

USD 13.01M

USD 72.15M

债务利息支出

USD 7.15M

USD 1.16M

USD 221.22M

USD 887.7M

USD 11.08M

USD 69.03M

USD 16.77M

普通股股本

USD 166.22M

2.45K

USD 11.08M

USD 83.13M

销售和管理费用

USD 42.64M

USD 74.23M

贸易债权人

USD 11.47M

应收帐款人

USD 51.05M

	股票	更改		日
Celltrion	KRW 122.94B		2.59T	2025-12
Cspc Pharmaceutical	CNY 2.87B		259.23M	2025-06
Divis Laboratories Ltd	INR 32.36B		910M	2025-03
Eli Lilly	USD 14.53B		785M	2026-03
Kangmei Pharma	CNY 2.45B		12.27M	2025-09
Knight Therapeutics	CAD 95.4M		2.91M	2024-03
Laboratorios Farma	EUR 327.67M		2.28M	2025-06
Medical Developments International	AUD 9.45M		679K	2025-06
Nektar Therapeutics	USD 14.46M		1.78M	2024-06
Organigram Holdings	CAD 132.71M		8.76M	2025-12
Pacira	USD 150.37M		2.49M	2026-03
Perrigo	USD 1.12B		27.6M	2026-03
Pharma Mar	EUR 53.12M		2.48M	2026-03
Qiagen NV	USD 301.89M		11.66M	2025-12
Sartorius	EUR 827.1M		34.9M	2026-03
Sino Biopharmaceutical	CNY 1.84B		156.17M	2024-06
Supernus Pharmaceuticals	USD 110.77M		1.71M	2026-03
Tilray	USD 282.79M		11.9M	2025-06
Zealand Pharma A/S	10.7M		9.9M	2024-12
Zz Pientze Pharmaceu	CNY 6.28B		553.86M	2026-03